ArticleNano-micro letters2026
Tailor-Made Nanoporous Metal-Organic Frameworks Via Molecular Engineering for Bilirubin-Specific Capture from Liver Failure Patients' Blood.
Article in Nano-micro letters, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Overcoming the albumin-bilirubin binding barrier to achieve specific recognition and high-efficiency capture of blood bilirubin remains a major clinical challenge in treating patients with hyperbilirubinemia due to liver failure, cholestasis, or other related conditions. Here, a molecular engineering-assisted functionalization strategy is proposed: programming the coordination environment of nanocrystalline frameworks with monodentate carboxylic acid ligands of varied carbon chain lengths to construct a family of zirconium-based UiO-66 nanoporous frameworks that act as bilirubin-specific molecular capture traps. The experimental results and molecular dynamics simulations confirm that the newly engineered UiO-66 nanoporous framework rapidly enriched albumin-bound bilirubin through short-range van der Waals/electrostatic effects; the internal Zr-μ
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.